Jalen Hurts is expected to miss the rest of the season after doctors discovered multiple blood clots in the Philadelphia Eagles quarterback's lungs, sources told NFL Network's Ian Rapoport and ESPN's Adam Schefter.
Hurts will undergo treatment involving blood thinners that is expected to sideline the three-time Pro Bowler for at least three months, sources informed of the diagnosis told Rapoport and Schefter.
Hurts' agent, Nicole Lynn, and the Eagles released a statement Monday detailing Hurts' condition. Lynn and the Eagles said Hurts has deep vein thrombosis and bilateral pulmonary emboli, meaning a blood clot traveled from his legs to his lungs.
https://t.co/aInIuUYiQJ
— Nicole Lynn (@AgentNicoleLynn) October 19, 2026
Hurts is "clinically stable and has no significant functional limitations," according to the statement, but will not be allowed to participate in football activities while on anticoagulation medication.
"Jalen's prognosis is very good, and we expect a full recovery," the statement said. "We anticipate that he will have the opportunity to resume contact football activities when off the blood thinners. In the meantime, he will remain active around the team and continue to condition. More importantly, we anticipate that he will have no long-term effects."
Hurts was initially diagnosed with what was described as a superficial blood clot in his calf. That diagnosis occurred in London before the Eagles' Week 5 game against the Jacksonville Jaguars at Tottenham Hotspur Stadium. Hurts played in that game -- a 19-17 loss for the Eagles -- despite the initial diagnosis and attempted 40 passes.
Sources told Rapoport that Hurts was in the hospital in London until 4 a.m. on the morning of the game. He did not sleep the night before the game because he was told that sleeping posed health risks associated with the clot, according to sources.
Hurts' clot is considered to be "provoked" -- meaning a favorable prognosis with treatment and care -- because he was cleated in his calf, sources told Rapoport.
The Eagles placed Hurts on injured reserve two days ago after consultations with numerous doctors and experts. Hurts already had been ruled out for Sunday's game against the Carolina Panthers, but the Eagles waited to make the roster move until after consulting with medical experts, according to sources.
Tanner McKee started in Hurts' place Sunday, completing 26 of 45 passes for 215 yards and a touchdown in Philadelphia's 25-14 home loss to Carolina.
Hurts took a cleat to his calf area on Oct. 4 against the Los Angeles Rams. He informed the Eagles' medical staff of the injury after practice on Oct. 8. and was back at practice the next day before the team left for London.
An ultrasound in London on Oct. 10 revealed Hurts' superficial blood clot. The Eagles said last week that their medical staff and London-based doctors reviewed the ultrasound results and "concluded that activity and mobility were important and that Jalen could safely play" against the Jaguars.
After returning to Philadelphia, Hurts underwent a follow-up ultrasound last Wednesday that revealed movement in the blood clot, prompting the Eagles to rule him out for the game against the Panthers.
Hurts hadn't missed more than two games in a season since becoming Philadelphia's quarterback in 2021. He is the fourth-leading passer in franchise history and has led the Eagles to three NFC East titles, two Super Bowl appearances and a victory over the Kansas City Chiefs two years ago in Super Bowl LIX, when he was named MVP.